Jeffrey W. Henderson
Board Member
Becton Dickinson & Co (BDX)Board Member
Halozyme Therapeutics, Inc. (HALO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeffrey W. Henderson
Jeffrey W. Henderson is recorded as Board Member at Becton Dickinson & Co (BDX) and Board Member at Halozyme Therapeutics, Inc. (HALO).
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2018-01-01–present
-
Current
2015-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Becton Dickinson & Co
Other people whose current roles at this company are on record from its filings.
- David F. Melcher Chairman
- Thomas E. Polen Chairman, Board Member
- Patrick K. Kaltenbach CTO
- Michelle Quinn General Counsel
- Christopher DelOrefice Chief Accounting Officer
- Pamela L. Spikner Chief Accounting Officer
- Bertram L. Scott Board Member
- Carrie L. Byington Board Member
- Carrie L. Byington, M.D. Board Member
- Christopher Jones Board Member
Leadership on record at Halozyme Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Helen Torley CEO, Board Member
- Darren Snellgrove CFO
- Elaine D. Sun CFO
- Nicole LaBrosse CFO
- Cortney Caudill COO
- Mark Snyder General Counsel
- Barbara Duncan Board Member
- Bernadette Connaughton Board Member
- Connie L. Matsui Board Member
- Dannielle Appelhans Board Member
Recent activity
No call appearances or filed executive changes recorded yet.